医疗保健领域的数位化转型和新兴技术 - 2022 年版

本报告调查和分析了医疗保健行业的数位化转型和先进技术，提供了有关 COVID-19 和通货膨胀的影响、数位化转型的关键因素和挑战以及先进技术的投资趋势的信息。

内容

第一章目的□□与设计

第 2 章数位化转型概述

• 数位化转型概述
• COVID-19 对数位化转型的影响

第 3 章数位化转型战略

• 数位化转型战略
• COVID-19 危机期间临床试验中断
• 处理临床试验中的困惑
• COVID-19 之后医生与製药公司销售代表之间的互动
• COVID-19 对社交媒体使用的影响

第 4 章数位化转型的目的

• 数位化转型的目的 - COVID-19
• 与製药行业的技术合作伙伴关係
• 数位化转型的目的
• 数位化转型的增长

第 5 章：数位化转型的障碍

第 6 章对数位化转型的关注

• 与数位化转型相关的问题
• 对数位化转型的担忧 - 用他们的话说

第 7 章数位化转型的必要性

第 8 章先进技术 - 投资趋势

• 先进技术
• COVID-19 对先进技术投资的影响
• 製造业机器人技术的未来
• 颠覆性的先进技术
• AI 和大数据的工作分析图
• 颠覆性的先进技术 - 用他们自己的话来说
• 案例研究 - 人工智能在药物发现过程中的作用
• 案例研究 - COVID-19 期间远程医疗的扩展
• 案例研究 - 使用 AI 进行药物再利用和筛选
• 案例研究 - AI 和个性化医疗的未来
• 案例研究 - AI 在对抗 COVID-19 的斗争中获胜

第 9 章主要发现摘要

第 10 章附录

第 11 章联繫人

The pharmaceutical industry is undergoing constant changes resulting from declining profit margins, cost pressure, necessity to replenish pipelines and maximize peak sales, while at the same time meeting stringent regulatory and legislative requirements. Although adoption of innovative technologies was seen as one of the ways to ease these pressures, the COVID-19 pandemic made digitalization of the sector even more pressing. Nevertheless, increasing inflation, fueled by the COVID-19 pandemic and geopolitical events such as the ongoing Ukraine conflict started to challenge digital transformation efforts in the healthcare sector.

Scope

In this report, GlobalData tracks the progress of digital transformation in the healthcare industry, examines the business preparedness to embrace innovations, and uncovers the current and future technology-related investment trends.

Objectives

• Benchmark the level of business readiness and adoption
• Better understand the business functions impacted the most
• Assess barriers to adoption
• Define requirements for success
• Determine the importance of emerging technologies to healthcare organizations
• Evaluate levels of investment
• Assess the impact of COVID-19 on digitalization efforts
• Explore how inflation is affecting digital transformation progress

Study Design

A total of 114 GlobalData Pharma clients and prospects participated in the 10-minute survey, which was fielded from September 14, 2022, to October 10, 2022.

Components of the report include -

• Scope of Digital Transformation Strategies - main objectives of digital strategy within the pharmaceutical industry providing respondent mix by region, company size, and respondent seniority.
• COVID-19 Pandemic and Digital Transformation - assesses the impact of COVID-19 on the speed of digital transformation and innovation in pharmaceutical industry.
• Inflation Impact on Digital Transformation - examines how the inflation is impacting digital transformation efforts.
• Challenges to Digital Transformation - highlights key hinderances healthcare organizations face when implementing digital transformation providing respondent mix by region and company size.
• Important Factors for Digital Transformation - determines the key factors required to successfully implement digital transformation providing respondent mix by company size.
• Uptake of Emerging Technologies - examines the key emerging technologies being invested in by healthcare organizations providing respondent mix by region and company size.
• Impact of emerging technologies on pharmaceutical sector - provides the analysis and insights on how technologies are being applied in the healthcare industry and what improvements in business processes these technologies can provide.

Reasons to Buy

• Stay up to date on the scope, challenges, and essentials for the digital transformation within the healthcare industry.
• Explore how innovations are transforming the healthcare industry and what impact on the sector these technologies will have in the near future.
• Develop and design your corporate strategies through an in-house expert analysis of the key factors of digital transformation and emerging technology in the healthcare sector.
• Develop business strategies by understanding the key factors of digital transformation and emerging technology in the healthcare sector.
• Identify emerging industry trends in the uptake of emerging technologies to gain a competitive advantage.

Table of Contents

Table of Contents

1. Objectives and Design

• 1.1.1. Respondent Mix
• 1.1.2. Key Findings

2. Overview of Digital Transformation

• 2.1.1. Overview of Digital Transformation
• 2.1.2. COVID-19 Impact of Digital Transformation

3. Digital Transformation Strategies

• 3.1.1. Digital Transformation Strategies
• 3.1.2. Clinical Trial Disruptions during COVID-19 Crisis
• 3.1.3. Addressing Clinical Trial Disruptions
• 3.1.4. Physician Interactions with Pharma Sales Reps Post-COVID-19
• 3.1.5. Impact of COVID-19 on Social Media Usage

4. Digital Transformation Objectives

• 4.1.1. Digital Transformation Objectives - COVID-19
• 4.1.2. Collaboration Between Pharmaceutical Industry and Tech
• 4.1.3. Digital Transformation Objectives
• 4.1.4. Digital Transformation Growth

5. Obstacles to Digital Transformation

6. Concerns Associated with Digital Transformation

• 6.1.1. Concerns Associated with Digital Transformation
• 6.1.2. Concerns Associated with Digital Transformation - In Their Words

7. Necessities for Digital Transformation

8. Emerging Technologies - Investment Trends

• 8.1.1. Emerging Technologies
• 8.1.2. COVID-19 Impact on Investment in Emerging Technologies
• 8.1.3. The Future of Robotics in Manufacturing
• 8.1.4. Disruptive Emerging Technologies
• 8.1.5. Job Analytic Graphs on AI and Big Data
• 8.1.6. Disruptive Emerging Technologies - In Their Words
• 8.1.7. Case Study - AI's Role in Drug Discovery Process
• 8.1.8. Case Study - Telehealth Expansion During COVID-19
• 8.1.9. Case Study - Drug Repurposing and Screening Using AI
• 8.1.10. Case Study - AI and the Future of Personalized Medicine
• 8.1.11. Case Study - AI Triumphs in the Fight Against COVID-19

9. Summary of Key Findings

• 9.1.1. Digital Transformation - In Their Words
• 9.1.2. Key Findings

10. Appendix

• 10.1.1. Bibliography
• 10.1.2. About the Authors

11. Contact Us